A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis

Cancer Research

Volumn 56, Issue 21, 1996, Pages 5079-5086

  Nagane, Motoo ^a   Coufal, Frank ^a   Lin, Hong ^a   Bögler, Oliver ^a   Cavenee, Webster K ^a,b   Huang, H J Su ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY KI 67;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CELL DEATH; CONTROLLED STUDY; DIAGNOSIS; GENE DELETION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; APOPTOSIS; CELL DIVISION; GLIOBLASTOMA; HUMANS; MICE; MICE, INBRED BALB C; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0029961912     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Deen, D. F., Chiarodo, A., Grimm, E. A., Fike, J. R., Israel, M. A., Kun, L. E., Levin, V. A., Marton, L. J., Packer, R. J., Pegg, A. E., Rosenblum, M. L. Suit, H. D., Walker, M. D., Wikstrand, C. J., Wilson, C. B., Wong, A. J., and Yung, W. K. A. Brain Tumor Working Group Report on the 9th international Conference on Brain Tumor Research and Therapy Organ System Program, National Cancer Institute. J Neuro-Oncol., 16: 243-272, 1993.
2. James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages Cancer Res., 48: 5546-5551, 1988.
3. Louis, D. N., and Gusella, J. F. A tiger behind many doors multiple genetic pathways to malignant glioma. Trends Genet., 11: 412-415, 1995.
4. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavenee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
5. Kamb, A., Gruis, N. A., Weaver, F. J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. R., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
6. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965-2969, 1992.
7. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309-4313, 1992.
8. Di, F. P., Pierce, J. H. Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., and Aaronson, S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell, 51: 1063-1070, 1987.
9. Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., and Waterfield, M. D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
10. Ro, J., North, S. M., Gallick, G. E., Hortobagyi, G. N., Gutterman, J. U., and Blick, M. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res., 48: 161-164, 1988.
11. Garcia de Palazzo, I. E., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53: 3217-3220, 1993.
12. Xu, Y. H., Richert, N., Ito, S., Merlino, G. T., and Pastan, I. Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc. Natl. Acad. Sci. USA, 81: 7308-7312, 1984.
13. Hunts, J., Ueda, M., Ozawa, S., Abe, O., Pastan, I., and Shimizu, N. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn. J. Cancer Res., 76: 663-666, 1985.
14. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature (Lond.), 313: 144-147, 1985.
15. Schlegel, J., Merdes, A., Stumm, G., Albert, F. K., Forsting, M., Hynes, N., and Kiessling, M. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human ghoblastoma. Int. J. Cancer, 56: 72-77, 1994.
16. Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Petterson, R. F., and Collins, V. P. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res., 51: 2164-2172, 1991.
17. Sugawa, N., Ekstrand, A. J., James, C. D., and Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl. Acad. Sci. USA, 87: 8602-8606, 1990.
18. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H.-J. S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731, 1994.
19. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
20. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
21. Arends, M. J., McGregor, A. H., and Wyllie, A. H. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am. J. Pathol., 144: 1045-1057, 1994.
22. Kerr, J. F., Winterford, C. M., and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
23. Nakagawa, S., Shiraishi, T., Kihara, S., and Tabuchi, K. Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch., 427: 175-179, 1995.
24. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death Cell, 74: 597-608, 1993.
25. Ponten, J., and Macintyre, E. H. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand., 74: 465-486, 1968.
26. Fields-Berry, S. C., Halliday, A. L., and Cepko, C. L. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. Proc. Natl. Acad. Sci. USA, 89: 693-697, 1992.
27. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J. Cell. Biol., 119: 493-501, 1992.
28. Herrin, D. L. and Schmidt, G. W. Rapid, reversible staining of northern blots prior to hybridization. Biotechniques, 6: 196-200, 1988.
29. Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., and Stein, H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133: 1710-1715, 1984.
30. Nagashima, T., DeArmond, S. J., Murovic, J., and Hoshino, T. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol., 67: 155-159, 1985.
31. Hoshino, T., Ahn, D., Prados, M. D., Lamborn, K., and Wilson, C. B. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodcoxyuridine labeling. Int. J. Cancer, 53: 550-555, 1993.
32. Reed, J. C. Bcl-2 and the regulation of programmed cell death J. Cell. Biol., 124: 1-6, 1994.
33. Todaro, G. J., Fryling, C., and De Larco, J. E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA, 77: 5258-5262, 1980.
34. Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N., and Rosenfeld, M. G. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (Washington DC), 247: 962-964, 1990.
35. Opresko, L. K., Chang, C. P., Will, B. H., Burke, P. M., Gill, G. N., and Wiley, H. S. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J. Biol. Chem., 270: 4325-4333, 1995.
36. Leoncini, L., Del Vecchio, M. T., Megha, T., Barbini, P., Galieni, P., Pilert, S., Sabattini, E., Gherlinzoni, F., Tosi, P., Kraft, R., and et al. Correlations between apoptotic and proliferate indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol., 142: 755-763, 1993.
37. Kerr, K. M., and Lamb, D. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. Br. J. Cancer, 50: 343-349, 1984.
38. Schiffer, D., Cavalla, P., Chio, A., Giordana, M. T., Marino, S., Mauro, A., and Migheli, A. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol., 87: 362-370, 1994.
39. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature (Lond.), 379: 88-91, 1996.
40. L. Nature (Lond.), 374: 811-813, 1995.
41. 2 checkpoint in p53-independent apoptosis induction by X-irradiation Mol. Cell. Biol., 15: 5849-5857, 1995.
42. Gonzalez-Garcia, M., Garcia, I., Ding, L., O'Shea, S., Boise, L. H., Thompson, C. B., and Nunez, G. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA, 92: 4304-4308, 1995.
43. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., and Reed, J. C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression Cancer Res., 54: 5501-5507, 1994.
44. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis Cancer Res., 55: 2576-2582, 1995.